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Abstract
Background: To evaluate clinical factors affecting postoperative vaulting in eyes that had achieved optimal
vaulting within the range of 250–750 μm following implantation of 12.6-mm V4c implantable collamer lenses (ICL).
Methods: A total of 236 eyes of 236 patients that had achieved optimal vaulting following implantation of
a 12.6-mm V4c ICL were retrospectively analyzed. Associations between postoperative vaulting and age,
preoperative anterior chamber depth (ACD), preoperative axial length (AL), preoperative white-to-white
diameter, preoperative pupil size, preoperative sulcus-to-sulcus diameter, and preoperative manifest refraction
spherical equivalent were investigated using simple regression, stepwise multiple regression, and multinomial
logistic regression analyses.
Results: Mean central vaulting at the 6-month follow-up was 519.0 ± 112.8 μm. Variables relevant to
postoperative vaulting were, in order of influence, preoperative ACD (β = 0.305, p < 0.001), preoperative pupil size
(β = 0.218, p < 0.001), and preoperative AL (β = 0.171, p = 0.006). Low preoperative pupil size was associated with
low optimal vaulting (250 to 450 μm), relative to that observed in the mid optimal vaulting group (451 to
550 μm) (odds ratio = 0.532, P = 0.021). Increasing preoperative ACD was associated with high optimal vaulting
(551 and 750 μm), relative to that observed the mid optimal vaulting group (odds ratio = 6.340, P = 0.034).
Conclusions: Myopic eyes with greater preoperative ACD, larger pupil size, and longer AL are predisposed to
higher postoperative vaulting following 12.6-mm V4c ICL implantation. Therefore, the extremes of these
parameters should be considered when choosing V4c ICL size.
Keywords: 12.6-mm V4c implantable collamer lenses, Postoperative vaulting, Preoperative pupil size,
Anterior chamber depth, Axial length
Background
The implantable collamer lens (ICL), a posterior cham-
ber phakic intraocular lens, effectively correct moderate
to high myopia [1, 2]. In addition, the ICL has been re-
ported to be safe and effective for the long-term correc-
tion of refractive errors in highly myopic eyes, for which
laser vision surgery is not appropriate [3]. Albeit its out-
standing benefit, postoperative complications have been
reported [4–6]. Most of these complications are associ-
ated with vaulting of the lens (i.e., distance between the
posterior surface of the ICL and the anterior surface of
the crystalline lens). High vaulting conditions lead to in-
creased intraocular pressure and inflammation by caus-
ing mechanical contact between the ICL and iris [6, 7].
Pigment dispersion, iris atrophy, secondary glaucoma,
and formation of metabolic cataracts have also been as-
sociated with high vaulting conditions [8, 9]. Low
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vaulting conditions have been reported to induce mech-
anical contact between the ICL and crystalline lens and
cause inadequate aqueous circulation in the perilenticu-
lar space. Mechanical contact between the ICL (posterior
surface) and crystalline lens (anterior surface), as well as
impaired circulation of aqueous humor, are considered
to play a crucial role in the development of anterior sub-
capsular cataracts [2, 4, 10].
The recently introduced Visian V4c ICL (STAAR Surgical
Company, Monrovia, CA, USA) has been designed with a
360-μm central hole (aquaport) allowing aqueous humor to
flow without the need for an iridotomy [11]. The presence
of the central hole does not significantly affect the position
of the ICL when comparing the V4c ICL and V4b ICL im-
plants [12]. Recent studies have suggested that optimal ICL
vaulting ranges from 250 to 750 μm [13–15]. ICL sizing
based on sulcus-to-sulcus (STS) diameter, white-to-white
(WTW) diameter, and anterior chamber depth (ACD) has
been established as the gold standard for achieving optimal
vaulting [13, 16, 17]. However, values at the low end of this
range (250 μm) may be associated with peripheral crystal-
line lens contact, while values at the high end of this range
(750 μm) may be associated with synechial angle closure.
Thus, both optimal vaulting status and the extent of vault-
ing achieved within the optimal range may be relevant to
the selection of ICL size.
Therefore, the present study aimed to analyze factors
that influence vaulting in 12.6-mm V4c ICL implanted
eyes that had achieved optimal vaulting between 250
and 750 μm. Only one size of V4c ICL was used for the
analysis to eliminate any confounding effects of size.
Methods
Ethical approval for the present retrospective study was
obtained from the Institutional Review Board of Yonsei
University College of Medicine, Seoul, South Korea (4–
2016-0357). The study adhered to the tenets of the Dec-
laration of Helsinki and followed good clinical practice.
Inclusion criteria for the present study were as follows: (i)
age 20–45 years; (ii) presence of myopia with a manifest re-
fraction spherical equivalent (MRSE) between − 4.00 and −
20.00 diopters (D); (iii) astigmatism between 0.00 and −
5.00 D; (iiii) eyes that had underwent the implantation of
12.6-mm V4c ICL using standardized techniques per-
formed by one surgeon (DSYK) between August 2013 and
February 2016 and achieved optimal vaulting within the
range of 250 and 750 μm. Among total 293 eyes, 7 eyes
(3%) showed vaulting smaller than 250 μm and 32 eyes
(11%) showed vaulting larger than 750 μm. Patients were
excluded from the analysis if they had keratoconus, previ-
ous ocular or intraocular surgery, acute or chronic corneal
infection (bacterial and fungal), corneal inflammation (kera-
titis, herpes zoster, ocular herpes, and Stevens-Johnson syn-
drome), glaucoma, cataract, uveitis, retinal detachment,
macular degeneration (age-related and myopic), an endo-
thelial cell density < 2000 cells/mm2, or an ACD from the
endothelium < 2.8 mm. One eye from each patient was in-
cluded in the analysis using randomization table.
All patients underwent complete ophthalmic examina-
tions, including uncorrected and corrected distance visual
acuity (Snellen lines), manifest refraction with the
cross-cylinder technique following retinoscopy, slit-lamp
microscopy (Haag-Streit, Gartenstadtstrasse, Köniz,
Switzerland), tonometry (noncontact tonometer; NT-530,
Nidek Co., Ltd., Aichi, Japan), autokeratometry (ARK-530A;
Nidek Co., Ltd.), automated pupillometry (VIP-200; Neurop-
tics Inc., Irvine, CA, USA), noncontact specular microscopy
(SP-3000P, Topcon Corporation, Tokyo, Japan), ultrasound
pachymetry for measurement of central corneal thickness
via contact method, A-scan ultrasonography, Visante optical
coherence tomography (OCT; Carl Zeiss Meditec AG, Jena,
Germany) for measurement of ACD (vertical distance from
the central corneal endothelium to the anterior lens capsule)
and horizontal WTW, and fundus examination. Ultrasound
biomicroscopy (UBM) was performed to measure the hori-
zontal STS diameter after instillation of proparacaine
(Alcaine; Alcon, Fort Worth, TX, USA) under standard
room lighting conditions. An independent physician per-
formed all ultrasound biomicroscopy examinations using the
UBM equipped with a 50 MHz transducer.
Six months after implantation, the central vaulting of the
ICL over the crystalline lens was measured in the
non-accommodative state using the Visante OCT. Central
vaulting was defined as the distance between the posterior
surface of the ICL and the anterior surface of the crystalline
lens at the center of the implant. Each measurement was
performed three times by one physician, and the average of
the three measurements was used in the analysis. A
non-accommodative state was ensured by asking patients to
avoid visual display terminal equipment or books for at least
3 h before examinations [18]. Measurements were taken
while the patient fixated on a collimated light-emitting diode
(focus at infinity) in a room with a luminance of 2 lux [19].
Surgical procedure
The surgery was performed through a 3.0-mm clear su-
perior corneal incision after dilation of the pupil with 0.5%
phenylephrine and 0.5% tropicamide (Mydrin-P, Santen
Pharmaceutical Co. Ltd., Osaka, Japan) under topical
anesthesia. The anterior chamber was filled with 1% so-
dium hyaluronate (Healon; Abbott Medical Optics, Santa
Ana, CA, USA), which was removed completely by man-
ual irrigation and aspiration at the end of surgery. Emme-
tropia was the target refraction in all cases. The ICL was
then inserted using an injector cartridge and correctly po-
sitioned. The V4c ICL power calculations were performed
according to the manufacturer’s guidelines using a modi-
fied vertex formula [20]. Following surgery, a topical
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antibiotic (Vigamox; Alcon Laboratories) and loteprednol
etabonate 0.5% (Lotemax; Bausch & Lomb, Rochester, NY,
USA) were applied four times a day for one week. After
the first week, loteprednol etabonate 0.5% was replaced
with 0.1% fluorometholone (Flumetholon; Santen Pharma-
ceutical). All eye drops were continued four times a day
for one month.
Statistical analysis
The Kolmogorov-Smirnov test was used to confirm the
normality of the data. Simple regression analyses and
stepwise multiple regression analyses were performed to
investigate the association between the amount of vault-
ing at 6 months after surgery and several preoperative
variables. The dependent variable was the central vault-
ing of the ICL over the crystalline lens using the Visante
OCT. Independent variables included patient age, gen-
der, preoperative MRSE, pupil size, WTW, STS, ACD,
and axial length (AL). Analysis of variance (ANOVA)
followed by Bonferroni post hoc testing were performed
to examine differences among subgroups, which were
based on the extent of postoperative vaulting (250 to
450 μm: low optimal vaulting; 451 to 550 μm: mid opti-
mal vaulting; and 551 and 750 μm: high optimal vault-
ing). Multinomial logistic regression analysis was
performed to ascertain the effects of age, gender, pre-
operative manifest refraction spherical equivalent
(MRSE), pupil size, WTW, STS, ACD, and AL on vault-
ing outcomes. Statistical analyses were performed using
SPSS version 22.0 software (IBM Corp., Armonk, NY,
USA). A p-value less than 0.05 was considered statisti-
cally significant.
Results
The mean patient age was 28.2 ± 5.1 (range 20–44)
years, and 71% (168/236) of the patients were females.
Table 1 summarizes the baseline clinical characteristics
of the 236 patients and descriptive data for preoperative
variables. The mean ICL power was − 11.2 ± 2.2 (range
− 5.5 to − 18.0) D. The mean central vaulting of the ICL
at 6 months after surgery was 519.0 ± 112.8 μm (range
250–740). All surgeries were uneventful, and no intraop-
erative complications were noted. No contact between
the ICL and crystalline lens was observed at either the
center or periphery of the implant in any patient during
the follow-up period.
Table 2 shows the simple regression analysis results be-
tween postoperative vaulting and eight variables. There
was significant association between postoperative vaulting
and preoperative pupil size (P = 0.004), and between post-
operative vaulting and preoperative ACD (P < 0.001). Ac-
cording to Table 3 showing the results of the stepwise
multivariate regression analysis, the explanatory variables
relevant to vaulting were preoperative ACD (P < 0.001,
standardized partial regression coefficient [β] = 0.305),
preoperative pupil size (P < 0.001, β = 0.218), and pre-
operative AL (P = 0.006, β = 0.171). The multiple regres-
sion equation was expressed as follows: central vaulting
(μm) = − 0.784 + (0.171 × preoperative ACD) + (0.038 ×
preoperative pupil size) + (0.017 × preoperative AL). The
standardized partial regression coefficient was calculated
to determine the magnitude of the influence of each vari-
able. Thus, preoperative ACD was the most relevant vari-
able, followed by preoperative pupil size and AL (Table 3).
Higher central vaulting was observed in eyes with greater
preoperative ACD, larger pupil size, or longer AL.
We also performed subgroup analyses according to de-
gree of postoperative vaulting. We observed a significant
difference in pupil size between the low optimal vaulting
and mid optimal vaulting groups (P = 0.031), and
Table 1 Baseline clinical characteristics of the study eyes
(236 eyes)
Characteristics Mean ± SD Range
Age (yrs) 28.2 ± 5.1 20 to 44
Gender (male/female) (%) 29/71
Laterality (right/left) (%) 48/52
Preoperative CDVA (Snellen lines) 0.97 ± 0.09 1.00 to 1.20
Preoperative sphere (D) −8.48 ± 2.28 −3.50 to −16.75
Refractive cylinder (D) −1.41 ± 0.84 −4.75 to 0.00
Preoperative MRSE (D) −9.19 ± 2.36 −4.00 to − 19.13
Preoperative pupil size (mm) 7.16 ± 0.64 4.70 to 8.60
Preoperative WTW (mm) 11.46 ± 0.28 10.85 to 12.80
Preoperative STS (mm) 11.65 ± 0.26 10.81 to 12.22
Preoperative ACD (mm) 3.35 ± 0.20 2.88 to 3.89
Preoperative AL (mm) 27.18 ± 1.16 23.88 to 30.82
Preoperative ECD (cells/mm2) 3018.4 ± 301.0 2229 to 3747
CDVA corrected distance visual acuity, MRSE manifest refraction spherical
equivalent, D diopters, WTW white-to-white, STS sulcus-to-sulcus, ACD
anterior chamber depth, AL axial length, ECD endothelial cell density, SD
standard deviation
Table 2 Simple regression analysis result between the
postoperative vaulting and eight variables
R2 P
Age (yrs) 0.012 0.092
Gender 0.003 0.370
MRSE (D) 0.011 0.103
Preoperative pupil size (mm) 0.036 0.004
Preoperative WTW (mm) 0.001 0.813
Preoperative STS (mm) 0.008 0.169
Preoperative ACD (mm) 0.072 < 0.001
Preoperative AL (mm) 0.015 0.057
MRSE manifest refraction spherical equivalent, D diopters, WTW white-to-white,
STS sulcus-to-sulcus, ACD anterior chamber depth, AL axial length
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between the low optimal vaulting and high optimal
vaulting groups (P = 0.002, Fig. 1). Significant differences
in ACD were also observed between the low optimal
vaulting and high optimal vaulting groups (P = 0.010)
(Table 4 and Fig. 1). Similar to findings observed for
ACD, our results suggested that smaller pupil diameters
were associated with low optimal vaulting values. Multi-
nomial logistic regression analysis revealed that low pre-
operative pupil size was associated with low optimal
vaulting (odds ratio = 0.532, P = 0.021, low vaulting vs
mid vaulting), and that increasing preoperative ACD was
associated with high optimal vaulting (odds ratio = 6.340,
P = 0.034, mid vaulting vs high vaulting).
Discussion
In the present study, we demonstrated that preoperative
ACD, followed by preoperative pupil size and preopera-
tive AL, significantly influenced postoperative vaulting
following 12.6-mm V4c ICL implantation in eyes that
had achieved optimal vaulting within the range of 250–
750 μm. Our findings are consistent with those of a re-
cent study in which stepwise multiple regression analysis
of patient age, preoperative refraction, WTW, horizontal
and vertical STS, ACD, AL, keratometric readings, and
ICL power revealed that ACD was the only factor signifi-
cantly associated with vaulting in eyes that had under-
gone implantation of V4c ICL [21]. This previous study
included 39 eyes of 39 patients that had undergone im-
plantation with wide range of V4c ICL overall diameters
(12.1-mm, 12.6-mm, 13.2-mm, or 13.7-mm) [21]. In re-
cent study identifying factors associated with the unex-
pected vaulting in eyes that had undergone implantation
of V4c ICL, authors concluded that smaller sized ICL
should be considered in patients with shallow ACD [22].
Postoperative vaulting was also associated with pre-
operative ACD, WTW, and horizontal and vertical STS
in eyes that had undergone implantation of a V4 or V4c
ICL [16]. In that study, the presence of a central hole
and the size of the implanted V4 or V4c ICL did not sig-
nificantly influence postoperative vaulting. Furthermore,
in a previous study that aimed to identify ocular and lens
parameters predictive of vaulting after ICL implantation,
eyes with a shallower ACD and/or a smaller WTW ex-
hibited significantly lower postoperative vaulting [23]. In
our study, because ICL size was limited to only
12.6-mm, the WTW and STS were relatively less im-
portant factors predictive of vaulting when compared
with the ACD.
Table 3 Results of stepwise multiple regression analysis to select variables relevant to central vaulting in 12.6-mm V4c implantable
collamer lens implanted eyes with postoperative optimal range of vaulting
Variables Partial regression
coefficient (B)
Standardized partial
regression coefficient (β)
P R2
< 0.001 0.144
Preoperative ACD (mm) 0.171 0.305 < 0.001
Preoperative pupil size (mm) 0.038 0.218 < 0.001
Preoperative AL (mm) 0.017 0.171 0.006
Constant −0.784
Variables in the table are ordered according to the strength of the contribution, which was based on the standardized partial regression coefficient (β)
ACD anterior chamber depth, AL axial length
Fig. 1 Subgroup analyses according to degree of postoperative vaulting. Low optimal vaulting, 250 to 450 μm; mid optimal vaulting, 451 to 550;
high optimal vaulting, 551 and 750 μm. ACD = anterior chamber depth. Error bars represent range
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Several previous studies have reported that changes in
pupil size in response to certain stimuli, such as photopic
light exposure or during accommodation, are associated
with postoperative vaulting [24–26]. In a previous study,
we demonstrated that pupil constriction in response to
photopic light exposure creates an antero-posterior vector
via iris constriction, in which the iris exerts pressure on
the ICL [23]. Because the V4C ICL has a central hole,
pressure equilibrium is quickly achieved between the an-
terior and posterior surfaces of the ICL, facilitating this
process (fountain effect of aquaport). In other words, the
net effect of pushing the ICL closer to the crystalline lens
is produced, subsequently decreasing central vaulting. Fur-
thermore, in a recent study of early postoperative changes
in vaulting and pupil size in eyes that had undergone V4c
ICL implantation, the authors reported a significant asso-
ciation between the changes in vaulting and those in pupil
size from 1 day to 1 month postoperatively, concluding
that pupil movement significantly influences postoperative
vaulting [21]. These results indicate that postoperative
vaulting is influenced by status of the anterior chamber. In
the present study, we demonstrated that, once ICL size
has been determined based on STS and WTW measure-
ments, preoperative pupil size significantly influences
postoperative vaulting. We speculate that, in association
with changes in aqueous humor dynamics via the central
hole in the V4c ICL, preoperative pupil size may influence
circumstances at the anterior region of the eye, especially
the region between the posterior cornea and anterior crys-
talline lens surface. Smaller pupils may exert greater pres-
sure on the ICL than larger pupils, consequently
decreasing vaulting. Indeed, our findings demonstrated
that smaller preoperative pupil size was associated with
low optimal vaulting, relative to values observed in the
mid optimal vaulting group (odds ratio = 0.532, P = 0.021).
Therefore, once ICL size has been determined based on
preoperative ACD, AL, WTW, and STS measurements,
surgeons should also consider preoperative pupil size
when predicting vaulting outcomes.
Preoperative AL was significantly associated with postop-
erative vaulting in Stepwise multiple regression analysis. To
the best of our knowledge, no previous reports have sug-
gested that preoperative AL significantly influences postoper-
ative vaulting. Considering that ACD is positively correlated
with AL in both eyes with normal and long AL, preoperative
AL may be relevant to postoperative vaulting [27].
The present study has several limitations, including its
retrospective design and a relatively short follow-up dur-
ation of 6 months. However, to our knowledge, our
study is the first to investigate the relationship between
postoperative vaulting and preoperative pupil size in
12.6-mm V4c ICL implanted eyes with optimal range of
vaulting between 250 and 750 μm. Further study investi-
gating the effect of preoperative pupil size on aqueous
humor dynamics in V4c ICL implanted eyes is warrant.
Conclusions
Our findings demonstrate that, among the studied vari-
ables, preoperative ACD most significantly influenced
postoperative vaulting in 12.6-mm V4c ICL implanted
eyes with optimal range of vaulting, followed by pre-
operative pupil size and AL. Therefore, surgeons should
take into account preoperative ACD, pupil size, and AL
when considering implantation of a 12.6-mm V4c ICL,
particularly in patients exhibiting extreme values, for
whom size adjustments may be required.
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